|
US4642316A
(en)
*
|
1985-05-20 |
1987-02-10 |
Warner-Lambert Company |
Parenteral phenytoin preparations
|
|
US6071923A
(en)
*
|
1994-09-16 |
2000-06-06 |
Bar-Ilan University |
Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases
|
|
US20020025921A1
(en)
*
|
1999-07-26 |
2002-02-28 |
Petito George D. |
Composition and method for growing, protecting, and healing tissues and cells
|
|
JP2002527449A
(ja)
*
|
1998-10-13 |
2002-08-27 |
藤沢薬品工業株式会社 |
環状テトラペプチド化合物およびその用途
|
|
US20070148228A1
(en)
*
|
1999-02-22 |
2007-06-28 |
Merrion Research I Limited |
Solid oral dosage form containing an enhancer
|
|
CN1308347C
(zh)
*
|
1999-04-28 |
2007-04-04 |
德克萨斯大学董事会 |
用于通过选择性抑制vegf来治疗癌症的组合物和方法
|
|
US6541661B1
(en)
*
|
1999-11-23 |
2003-04-01 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
EP2083005A1
(en)
*
|
2000-09-29 |
2009-07-29 |
TopoTarget UK Limited |
Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
|
|
GB0023983D0
(en)
*
|
2000-09-29 |
2000-11-15 |
Prolifix Ltd |
Therapeutic compounds
|
|
WO2002030879A2
(en)
*
|
2000-09-29 |
2002-04-18 |
Prolifix Limited |
Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
|
|
US20050119305A1
(en)
*
|
2001-03-21 |
2005-06-02 |
Masao Naka |
Il-6 production inhibitors
|
|
PL368129A1
(en)
*
|
2001-08-09 |
2005-03-21 |
Ono Pharmaceutical Co, Ltd. |
Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
|
|
US6897220B2
(en)
*
|
2001-09-14 |
2005-05-24 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
US7041699B2
(en)
*
|
2002-01-11 |
2006-05-09 |
Matthias Rath |
Nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer
|
|
US20050288227A1
(en)
*
|
2002-02-15 |
2005-12-29 |
Marks Paul A |
Use of thioredoxin measurements for diagnostics and treatments
|
|
EP1482962A4
(en)
*
|
2002-02-15 |
2009-12-23 |
Sloan Kettering Inst Cancer |
METHOD OF TREATING THIOREDOXIN-MEDIATED DISEASES (TRX)
|
|
US20070060614A1
(en)
*
|
2002-03-04 |
2007-03-15 |
Bacopoulos Nicholas G |
Methods of treating cancer with hdac inhibitors
|
|
US7148257B2
(en)
*
|
2002-03-04 |
2006-12-12 |
Merck Hdac Research, Llc |
Methods of treating mesothelioma with suberoylanilide hydroxamic acid
|
|
EP2322160A1
(en)
*
|
2002-03-04 |
2011-05-18 |
Merck HDAC Research, LLC |
Methods of inducing terminal differentiation
|
|
US20040132825A1
(en)
*
|
2002-03-04 |
2004-07-08 |
Bacopoulos Nicholas G. |
Methods of treating cancer with HDAC inhibitors
|
|
WO2003087066A1
(en)
*
|
2002-04-11 |
2003-10-23 |
Sk Chemicals, Co., Ltd. |
α,β-UNSATURATED HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS
|
|
MXPA04010199A
(es)
*
|
2002-04-15 |
2005-07-05 |
Sloan Kettering Inst Cancer |
Terapia en combinacion para el tratamiento de cancer.
|
|
US8883148B2
(en)
*
|
2002-04-26 |
2014-11-11 |
Asan Laboratories Company (Cayman), Limited |
Prevention of joint destruction
|
|
US20080004311A1
(en)
*
|
2002-11-12 |
2008-01-03 |
Alcon, Inc. |
Histone deacetylase inhibitors for treating degenerative diseases of the eye
|
|
WO2004064727A2
(en)
*
|
2003-01-16 |
2004-08-05 |
Georgetown University |
Method of cancer treatment using hdac inhibitors
|
|
CA2518318A1
(en)
*
|
2003-03-17 |
2004-09-30 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US20040220242A1
(en)
*
|
2003-05-02 |
2004-11-04 |
Leland Shapiro |
Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditions
|
|
EP1491188A1
(en)
*
|
2003-06-25 |
2004-12-29 |
G2M Cancer Drugs AG |
Topical use of valproic acid for the prevention or treatment of skin disorders
|
|
PT1663194E
(pt)
*
|
2003-08-26 |
2010-07-06 |
Merck Hdac Res Llc |
Utilizaão de saha para o tratamento de mesotelioma
|
|
US20060270016A1
(en)
*
|
2003-11-14 |
2006-11-30 |
Holm Per S |
Novel adenoviruses, nucleic acids that code for the same and the use of said viruses
|
|
WO2005051430A1
(de)
*
|
2003-11-14 |
2005-06-09 |
Per Sonne Holm |
Neue verwendung von adenoviren und dafür codierenden nukleinsäuren
|
|
GB0401876D0
(en)
*
|
2004-01-28 |
2004-03-03 |
Vereniging Het Nl Kanker I |
New use for cancer antigen
|
|
EP1725873B1
(en)
*
|
2004-02-27 |
2009-07-22 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Pharmacodynamic assays using flow cytometry.
|
|
EP1591109B1
(en)
*
|
2004-04-30 |
2008-07-02 |
TopoTarget Germany AG |
Formulation comprising histone deacetylase inhibitor exhibiting biphasic release
|
|
EP1787657A1
(en)
*
|
2004-08-06 |
2007-05-23 |
Ono Pharmaceutical Co., Ltd. |
Therapeutic agent for psychoneurotic disease
|
|
WO2006016680A1
(en)
*
|
2004-08-09 |
2006-02-16 |
Astellas Pharma Inc. |
Hydroxyamide compounds having activity as inhibitors of histone deacetylase (hdac)
|
|
WO2006060382A2
(en)
*
|
2004-11-30 |
2006-06-08 |
Trustees Of The University Of Pennsylvania |
Use of hdac and/or dnmt inhibitors for treatment of ischemic injury
|
|
EP1830864A2
(de)
*
|
2004-12-31 |
2007-09-12 |
Per Sonne Holm |
E1 -minus adenoviren und deren verwendung
|
|
KR101346886B1
(ko)
*
|
2005-01-21 |
2014-01-02 |
아스텍스 테라퓨틱스 리미티드 |
제약 화합물
|
|
CA2596210C
(en)
*
|
2005-02-03 |
2014-07-08 |
Topotarget Uk Limited |
Combination therapies using hdac inhibitors
|
|
US20060229237A1
(en)
*
|
2005-04-07 |
2006-10-12 |
Yih-Lin Chung |
Treatment of gastrointestinal distress
|
|
GB0509225D0
(en)
*
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Inhibitors of enzymatic activity
|
|
ES2380887T3
(es)
*
|
2005-05-13 |
2012-05-21 |
Topotarget Uk Limited |
Formulaciones farmacéuticas de inhibidores de la HDAC
|
|
EP1743654A1
(en)
*
|
2005-07-15 |
2007-01-17 |
TopoTarget Germany AG |
Use of inhibitors of histone deacetylases in combination with NSAID for the therapy of cancer and/or inflammatory diseases
|
|
JP2009504751A
(ja)
*
|
2005-08-19 |
2009-02-05 |
アメリカ合衆国 |
ヒストンデアセチラーゼ阻害薬の局所製剤及びその使用方法
|
|
RU2008108221A
(ru)
*
|
2005-09-07 |
2009-10-20 |
Плекссикон, Инк. (Us) |
Соединения, активные в отношении ppar (рецепторов активаторов пролиферации пероксисом)
|
|
US8828392B2
(en)
*
|
2005-11-10 |
2014-09-09 |
Topotarget Uk Limited |
Histone deacetylase (HDAC) inhibitors (PXD101) for the treatment of cancer alone or in combination with chemotherapeutic agent
|
|
US8445198B2
(en)
*
|
2005-12-01 |
2013-05-21 |
Medical Prognosis Institute |
Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
|
|
KR20080103977A
(ko)
*
|
2006-02-22 |
2008-11-28 |
4에스체 악티엔게젤샤프트 |
Ｅｇ５ 키네신 조절자로서 인돌로피리딘
|
|
US8530493B2
(en)
*
|
2006-02-22 |
2013-09-10 |
4Sc Ag |
Indolopyridines as Eg5 kinesin modulators
|
|
EP1839656A1
(en)
*
|
2006-03-31 |
2007-10-03 |
TopoTarget Germany AG |
Use of valproic acid for the topical treatment of mild to moderate acne vulgaris
|
|
WO2007129062A1
(en)
*
|
2006-05-08 |
2007-11-15 |
Astex Therapeutics Limited |
Pharmaceutical combinations of diazole derivatives for cancer treatment
|
|
EP2040731A4
(en)
*
|
2006-06-09 |
2010-05-19 |
Merrion Res Iii Ltd |
SOLID DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING AN ACTIVATOR
|
|
WO2008011603A2
(en)
*
|
2006-07-20 |
2008-01-24 |
Wisconsin Alumni Research Foundation |
Modulating notch1 signaling pathway for treating neuroendocrine tumors
|
|
WO2008058287A1
(en)
*
|
2006-11-10 |
2008-05-15 |
Syndax Pharmaceuticals, Inc. |
COMBINATION OF ERα+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER
|
|
US8796330B2
(en)
*
|
2006-12-19 |
2014-08-05 |
Methylgene Inc. |
Inhibitors of histone deacetylase and prodrugs thereof
|
|
US7915245B2
(en)
*
|
2007-02-01 |
2011-03-29 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions of trail-death receptor agonists/activators
|
|
US8012695B2
(en)
*
|
2007-02-14 |
2011-09-06 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions relating to promoter regulation by MUC1 and KLF proteins
|
|
WO2008136838A1
(en)
*
|
2007-05-04 |
2008-11-13 |
Trustees Of Dartmouth College |
Novel amide derivatives of cddo and methods of use thereof
|
|
GB2454118B
(en)
*
|
2007-06-06 |
2010-06-02 |
Univ Maryland |
Hdac inhibitors and hormone targeted drugs for the treatment of cancer
|
|
WO2009146034A2
(en)
*
|
2008-03-31 |
2009-12-03 |
Takeda Pharmaceutical Company Limited |
Mapk/erk kinase inhibitors and methods of use thereof
|
|
US20090270497A1
(en)
*
|
2008-04-24 |
2009-10-29 |
Pharmacyclics, Inc. |
Treatment of Non-Localized Inflammation with pan-HDAC Inhibitors
|
|
US8637554B2
(en)
*
|
2008-05-07 |
2014-01-28 |
The Trustees Of The University Of Pennsylvania |
Methods for treating thyroid cancer
|